- cafead May 07, 2024 at 11:42: AM
via Mark your calendars: Eli Lilly will come before the FDA’s advisory committee to discuss Alzheimer’s disease medicine donanemab June 10.
The Peripheral and Central Nervous System Drugs Advisory Committee will meet from 9 a.m. to 5 p.m. ET on that date to discuss the application for donanemab in early symptomatic Alzheimer’s, Lilly announced in a Tuesday statement.
article source
The Peripheral and Central Nervous System Drugs Advisory Committee will meet from 9 a.m. to 5 p.m. ET on that date to discuss the application for donanemab in early symptomatic Alzheimer’s, Lilly announced in a Tuesday statement.
article source